Alignment Healthcare (ALHC) Drops 12% on Medicare Flat Funding

We recently published 10 Big Names With Painful Declines. Alignment Healthcare Inc. (NASDAQ:ALHC) was one of the worst performers on Tuesday.

Alignment Healthcare fell by 11.97 percent on Tuesday to close at $20.96 apiece as investors unloaded positions in listed insurers following the lower-than-expected preliminary payment proposals for the Medicare Advantage program.

According to the Centers for Medicare and Medicaid Services (CMS), net average payment is projected to increase by only 0.09 percent, far lower than the 4 to 6 percent growth as expected by analysts.

Additionally, the CMS proposed tighter risk-adjustment rules, such as excluding diagnoses made only via audio calls and some chat reviews in 2027.

Alignment Healthcare Inc. (NASDAQ:ALHC) dropped alongside its counterparts, namely UnitedHealth Group, CVS Health, Centene Corp., and Oscar Health, among others, having raised fears over how the companies would fare given their exposure to the government-sponsored program.

Meanwhile, investors will be closely watching out for Alignment Healthcare Inc.’s (NASDAQ:ALHC) short-term outlook following updates to the Medicare program. The company, based on its historical earnings reporting dates, would release its financial and operating highlights in the last week of February 2026.

While we acknowledge the potential of ALHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.